Healthcare Global Enterprises per share figures

Share price at each year-end
Tap a line for its trendCurrentlast 12MFY26Mar 2026FY25Mar 2025FY24Mar 2024FY23Mar 2023FY22 and earlierAlpha Plus
₹1.55₹0.97₹3.19₹3.46₹2.11
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
₹1.55₹0.96₹3.14₹3.43₹2.10
₹92.56₹92.56₹66.17₹59.28₹61.86
₹182.58₹176.89₹159.44₹137.28₹121.80
—₹24.12₹22.75₹20.43₹18.08
₹3.82₹3.82₹7.76₹7.10₹8.51
14.414.413.913.913.9
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HCG₹585.60

Healthcare Global Enterprises Ltd.

· Pharma & Health
₹ CrorePeersAPOLLOHOSPFORTISRAINBOWJLHLCORONAMARKSANSMETROPOLISPARKHOSPSMcap ₹8,427 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
₹ per share
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Current/LTM
TTM · last close
Basic EPS2.113.463.190.971.55
Diluted EPS2.103.433.140.961.55
Book Value per Share61.8659.2866.1792.5692.56
Revenue per Share121.80137.28159.44176.89182.58
Cash Flow per Share18.0820.4322.7524.12—
Free Cash Flow per Share8.517.107.763.823.82
Shares Outstanding (cr)13.913.913.914.414.4
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.